scholarly journals The Role of the Joint Procurement Agreement during the COVID-19 Pandemic: Assessing Its Usefulness and Discussing Its Potential to Support a European Health Union

2020 ◽  
Author(s):  
Emma McEvoy ◽  
Delia Ferri
2020 ◽  
Vol 11 (4) ◽  
pp. 851-863 ◽  
Author(s):  
Emma MCEVOY ◽  
Delia FERRI

In 2014, the European Joint Procurement Agreement (JPA) was introduced as an innovative instrument to organise the procurement of vaccines and medications in preparation for pandemics. An overriding purpose of the JPA is to secure equitable and cost-effective access to medical supplies for participating EU Member States during serious health crises. This article aims to understand the current use of the JPA in response to the COVID-19 pandemic. Post-analysis of the recent use of the JPA, the article will discuss how the regional procurement mechanism can be strengthened to support the development of a European Health Union. In particular, the article will firstly question whether the four recent JPA procurement actions facilitated equitable access to medical supplies and services. Secondly, it will ask whether the centralised procurement actions preserved the integrity of the Internal Market. The importance and originality of this study are that it addresses an instrument, the JPA, which has been largely overlooked by legal scholars, and it explores how the provisions for the joint procurement of medical countermeasures as included in Article 5 of Decision 1082/2013/EU on serious cross-border threats to health could be extended to support the functioning of a European Health Union.


1990 ◽  
Vol 10 (4) ◽  
pp. 391-416 ◽  
Author(s):  
Ellen M. Immergut

ABSTRACTThe medical profession is reputed to control decision-making in medical care to such an extent that one can speak of professional dominance. Yet West European health policies have radically changed the working conditions and incomes of doctors in many countries. Why have some governments been able to ‘socialize’ medicine? This article seeks to refute the view that the medical profession exercises a universal veto power. In contrast to scholars who explain medical influence in terms of singular characteristics of the medical profession or through the historical process of professionalization, this essay focuses on the properties of distinct political systems that make them vulnerable to medical influence. It argues that we have veto points within political systems and not veto groups within societies. By comparing the lobbying efforts of medical associations in Switzerland, France, and Sweden, the article analyses the role of political institutions in accounting for different patterns of medical association influence on health policy.


2020 ◽  
Vol 71 (1) ◽  
pp. 81-87
Author(s):  
Albert Sanchez-Graells

This piece reflects on the role of public procurement regulation in the face of a situation, such as the COVID-19 pandemic, generating an extremely urgent need for the public sector to buy additional supplies and equipment. Counterintuitively, at a time of heightened public expenditure, public procurement rules are ‘deactivated’. That does not mean that unusual procurement mechanisms are not ‘activated’, though, as the example of the EU’s Joint Procurement Agreement shows. It also does not mean that ‘reactivating’ public procurement regulation will not present challenges, some of which deserve careful consideration.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Monica Giancotti ◽  
Milena Lopreite ◽  
Marianna Mauro ◽  
Michelangelo Puliga

AbstractThis article examines the main factors affecting COVID-19 lethality across 16 European Countries with a focus on the role of health system characteristics during the first phase of the diffusion of the virus. Specifically, we investigate the leading causes of lethality at 10, 20, 30, 40 days in the first hit of the pandemic. Using a random forest regression (ML), with lethality as outcome variable, we show that the percentage of people older than 65 years (with two or more chronic diseases) is the main predictor variable of lethality by COVID-19, followed by the number of hospital intensive care unit beds, investments in healthcare spending compared to GDP, number of nurses and doctors. Moreover, the variable of general practitioners has little but significant predicting quality. These findings contribute to provide evidence for the prediction of lethality caused by COVID-19 in Europe and open the discussion on health policy and management of health care and ICU beds during a severe epidemic.


2003 ◽  
Vol 37 (6) ◽  
pp. 592-608 ◽  
Author(s):  
Ana Rico ◽  
Richard B. Saltman ◽  
Wienke G. W. Boerma

Sign in / Sign up

Export Citation Format

Share Document